INDEX
877
in intraabdominal abscess, 177–178, 373
in pregnancy, 805
in pulmonary embolism, 555t
in surgical infections, 398
in urinary obstruction, 322
in urinary tract infection, 185, 383
Unfractionated heparin (UFH). See also Low-molecular-
weight heparin
for acute arterial insufficiency, 636
complications, 556–557, 828–829, 829t
for deep venous thrombosis/pulmonary embolism
prophylaxis, 559–561, 560t, 644, 827t
treatment, 554–557, 645, 827t
for disseminated intravascular coagulation,
421, 622
dosing and adjustment, 826, 826t
factors modifying effects, 827–828, 828t
in hemodialysis, 337
hyperkalemia and, 40
indications and administration, 827, 827t
intravenous, weight-based dosing, 555t
vs. low-molecular-weight heparin, 830t
mechanisms of action, 825–826
in peritoneal dialysis, 340
pharmacology, 826
postoperative hypocoagulability and, 521
in pregnancy, 827t, 838, 839t
protein binding, 89t
renal clearance, 90
for ST-segment elevation myocardial infarction, 509
in total parenteral nutrition solution, 128
for unstable angina or non-STEMI, 504, 505t
Unstable angina pectoris (USA), 502–504, 505t
Upper airway obstruction, 254
Urea, in acute renal failure, 315–316
Urea-bridged gelatin, 229
Urea clearance, 317, 333
Urea nitrogen appearance (UNA), 333
Uremia, 61t, 62
Ureteral obstruction, 321–322
Urinalysis, in acute renal failure, 317
Urinary catheter–associated infections, 382–383
Urinary obstruction, 321–322
Urinary tract infections
clinical features, 366
complications, 366
in diabetes, 375
essentials of diagnosis, 365
general considerations, 366
imaging studies, 185–186
microbiologic etiology, 366
pathophysiology, 366
in pregnancy, 811–812
treatment, 367
Urine concentration, 23
Urokinase, 410t, 558, 637, 836t.
See also Thrombolytic therapy
Urticaria, drug-related, 613, 614t
Uterine atony, 818
Uterine inversion, 817
Uterine rupture, 817, 820
V
Valacyclovir, 315t, 627
Valproate sodium, 665, 665t
Valvular heart disease
aortic regurgitation, 198, 475
aortic stenosis, 475
cardiac sufficiency following surgery for, 530
clinical features, 474–475
emboli, 476
essentials of diagnosis, 474
general considerations, 474
imaging studies, 475
infective endocarditis. See Endocarditis
mitral senosis, 198, 475, 494
native valve regurgitation, 475
native valve stenosis, 475
paravalvular leaks and valve dehiscence, 476
during pregnancy, 493–494
prosthetic valve dysfunction, 475–476
Vancomycin
for C. difficile–associated diarrhea, 387
for dialysis-related peritonitis, 339t
resistance to, 376t, 389
therapeutic ranges, 92t
Vancomycin-insensitive Staphylococcus aureus (VISA), 390
Variant-Creutzfeldt-Jakob disease,
transfusion-associated, 82t
Variceal bleeding
clinical features, 707, 716
differential diagnosis, 716
essentials of diagnosis, 716
general considerations, 707, 716
treatment, 428, 709–710, 717
Varicella-zoster virus, 626–627
Vascular surgery patient
complications, 655–656
nutritional management, 651–652
postoperative care, 653–654
preoperative risk assessment, 652–653
renal failure in, 653–654
respiratory management, 651
Vasculitis, 620–621, 620t, 621t
Vasodilators, 237, 244–245
Vasopressin. See also Antidiuretic hormone
for diabetes insipidus, 33
in hypovolemic shock, 224
for septic shock, 237
for variceal bleeding, 717
Vecuronium, 89t, 107t, 109
Vena cava filters
inferior, 558, 561, 647, 821
Venography, 643
V
e
nous air embolism, 141
Venous thromboembolism. See Deep venous thrombosis;
Pulmonary embolism
Ventilation-perfusion index (V/QI), 198
Ventilation-perfusion (V/Q) mismatch, 251
Ventilation-perfusion (V/Q) scan, 153, 154, 550–552, 551t
Ventilator-associated pneumonia (VAP)
in ARDS, 307
diagnosis, 277, 400–401